Cardiff Oncology, Inc. Q3 2023 Earnings Call Transcript
CRDF Stock | USD 2.66 0.05 1.92% |
Roughly 69% of Cardiff Oncology's investor base is looking to short. The analysis of the overall investor sentiment regarding Cardiff Oncology suggests that many traders are alarmed. The current market sentiment, together with Cardiff Oncology's historical and current headlines, can help investors time the market. In addition, many technical investors use Cardiff Oncology stock news signals to limit their universe of possible portfolio assets.
Cardiff |
Cardiff Oncology, Inc. Q3 2023 Earnings Call Transcript November 2, 2023 Cardiff Oncology, Inc. beats earnings expectations. Reported EPS is -0.22, expectations were -0.29. Operator Welcome to the Cardiff Oncology third-quarter 2023 financial results and corporate update conference call. Operator Instructions. As a reminder, this call is being recorded today, November 2, 2023. I
Read at finance.yahoo.com
Cardiff Oncology Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Cardiff Oncology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cardiff Oncology Fundamental Analysis
We analyze Cardiff Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardiff Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardiff Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Cardiff Oncology is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Cardiff Oncology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardiff Oncology stock to make a market-neutral strategy. Peer analysis of Cardiff Oncology could also be used in its relative valuation, which is a method of valuing Cardiff Oncology by comparing valuation metrics with similar companies.
Peers
Cardiff Oncology Related Equities
INAB | In8bio | 23.33 | ||||
KOD | Kodiak Sciences | 11.39 | ||||
LYRA | Lyra Therapeutics | 10.53 | ||||
SLS | Sellas Life | 2.65 | ||||
MREO | Mereo BioPharma | 0.55 | ||||
CGTX | Cognition Therapeutics | 0.00 | ||||
DAWN | Day One | 0.65 | ||||
BOLT | Bolt Biotherapeutics | 1.56 | ||||
LTRN | Lantern Pharma | 1.56 | ||||
AUTL | Autolus Therapeutics | 1.81 | ||||
PDSB | PDS Biotechnology | 1.83 | ||||
CGEM | Cullinan Oncology | 2.08 | ||||
RVPH | Reviva Pharmaceuticals | 3.23 | ||||
CUE | Cue Biopharma | 4.10 | ||||
RVPHW | Reviva Pharmaceuticals | 4.35 | ||||
NLSP | NLS Pharmaceutics | 10.36 | ||||
RNAZ | Transcode Therapeutics | 20.00 |
Complementary Tools for Cardiff Stock analysis
When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
CEOs Directory Screen CEOs from public companies around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |